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ARTICLE
Serial femtosecond crystallography on
in vivo-grown crystals drives elucidation of
mosquitocidal Cyt1Aa bioactivation cascade
Guillaume Tetreau 1,13, Anne-Sophie Banneville1,13, Elena A. Andreeva 1,13, Aaron S. Brewster 2,13,
Mark S. Hunter3, Raymond G. Sierra 3, Jean-Marie Teulon1, Iris D. Young 2, Niamh Burke1,
Tilman A. Grünewald 4, Joël Beaudouin1, Irina Snigireva 4, Maria Teresa Fernandez-Luna5,12, Alister Burt 1,
Hyun-Woo Park5,6, Luca Signor 1, Jayesh A. Bafna7, Rabia Sadir1, Daphna Fenel1, Elisabetta Boeri-Erba1,
Maria Bacia1, Ninon Zala1, Frédéric Laporte 8, Laurence Després 8, Martin Weik 1, Sébastien Boutet 3,
Martin Rosenthal 4, Nicolas Coquelle 9, Manfred Burghammer4, Duilio Cascio10, Michael R. Sawaya 10,
Mathias Winterhalter 8, Enrico Gratton11, Irina Gutsche 1, Brian Federici5, Jean-Luc Pellequer 1,
Nicholas K. Sauter2 & Jacques-Philippe Colletier 1✉
Cyt1Aa is the one of four crystalline protoxins produced by mosquitocidal bacterium Bacillus
thuringiensis israelensis (Bti) that has been shown to delay the evolution of insect resistance in
the field. Limiting our understanding of Bti efficacy and the path to improved toxicity and
spectrum has been ignorance of how Cyt1Aa crystallizes in vivo and of its mechanism of
toxicity. Here, we use serial femtosecond crystallography to determine the Cyt1Aa protoxin
structure from sub-micron-sized crystals produced in Bti. Structures determined under var-
ious pH/redox conditions illuminate the role played by previously uncharacterized disulfide-
bridge and domain-swapped interfaces from crystal formation in Bti to dissolution in the
larval mosquito midgut. Biochemical, toxicological and biophysical methods enable the
deconvolution of key steps in the Cyt1Aa bioactivation cascade. We additionally show that
the size, shape, production yield, pH sensitivity and toxicity of Cyt1Aa crystals grown in Bti
can be controlled by single atom substitution.
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Mosquitoes remain the organisms most harmful tohuman health, transmitting diseases such as malaria,dengue fever, and filariasis. Disease prevention relies
mostly on the control of mosquito vector populations by use of
chemical insecticides but these elicit resistance whilst also
harming crustaceans, bees, and fish. A safer alternative to che-
micals is the dissemination of sporulated formulations of the
mosquitocidal bacterium, Bacillus thuringiensis subspecies israe-
lensis (Bti), which upon ingestion by mosquito larvae destroys
their midgut, killing them1. The active ingredient of Bti is a
parasporal body that contains three natural sub-micron-sized
crystals of four highly efficient mosquito-specific toxins, namely
Cyt1Aa, Cry11Aa and co-crystallizing Cry4Aa and Cry4Ba. Fol-
lowing ingestion by mosquito larvae, the crystals promptly dis-
solve in the alkaline environment of the gut (pH ~11), releasing
protoxins that are activated into toxins through proteolytic
cleavage of propeptides by gut enzymes. Whereas Cyt1Aa directly
interacts with lipids from gut cell membranes, Cry toxins require
interaction with membrane-bound receptors. Each activated
protein eventually self-assembles into cytolytic oligomers that
perforate gut cells, leading to mosquito larvae death1. Cyt1Aa
oligomers can additionally serve as substitution receptors for Cry
toxins, enabling them to kill cells even in the absence of mosquito
receptors. This synergy explains how Bti is able to evade resis-
tance and makes Cyt1Aa the key element of its mosquitocidal
arsenal. However, the molecular determinants of Cyt1Aa crys-
tallization in Bti cells and of crystal dissolution in the mosquito
midgut remain unclear, and the mechanism by which oligomers
form and exert direct toxicity to mosquito gut cells is actively
debated2,3. Most investigators agree that Cyt1Aa binds directly to
lipids and acts as a receptor for Bti Cry toxins. However, two
contrasting models—not necessarily incompatible—have been
proposed for toxicity2,3. In one, Cyt1Aa monomers assemble into
monovalent cation-selective channels with a radius of 6–20 Å
spanning through the membrane, thereby killing cells by ion
leakage (“pore-forming” model)4–6. In the other, monomers form
oligomers on the membrane surface causing lipid faults that result
in cell lysis (“detergent” model)7.
Here, we use serial femtosecond crystallography (SFX) at an X-
ray free electron laser (XFEL) to identify the features governing
the in vivo crystallization of Cyt1Aa in Bti cells, and to track the
structural dynamics driving natural crystal dissolution in the
alkaline mosquito larvae gut. Use of complementary biophysical,
biochemical, and toxicological methods in combination with
mutagenesis at positions identified in difference electron density
maps allows us to formulate a new model for the Cyt1Aa
bioactivation cascade, from self-inhibition and in vivo crystal-
lization in Bti cells to oligomer formation and cell lysis. By
illustrating how the crystal properties and toxicity of naturally
crystalline Cyt1Aa can be tuned by single atom substitutions at
strategic positions, our results pave the way for a rational tailoring
of its properties to human needs.
Results
The N-terminal propeptide governs in vivo crystallization. We
produced sub-micron-sized crystals of Cyt1Aa in vivo by
recombinant expression in an acrystalliferous strain of Bti (4Q7)8.
Crystal size, shape, integrity, and diffraction power were assessed
by scanning electron microscopy (SEM) (Fig. 1a), atomic force
microscopy (AFM) (Fig. 1b), transmission electron microscopy
(TEM) (Fig. 1c), and serial synchrotron crystallography, respec-
tively, revealing highly ordered bipyramidal crystals (0.6 × 0.6 ×
0.9 μm3, corresponding to ~180,000 unit cells) which diffract
to ~4.0 Å resolution when exposed to a sub-microfocus syn-
chrotron X-ray beam (0.7 μm FWHM; ESRF-ID13) at 100 K9
(Supplementary Fig. 1). Using SFX at the CXI-SC3 micro-focused
beamline10 of the Stanford Linear Accelerator Center (SLAC)
Linac Coherent Light Source (LCLS), diffraction data extending
to 1.86 Å could be collected at room temperature (RT) for the
wild-type (WT) Cyt1Aa protoxin at pH 7 (“pH7” dataset,
Table 1), from sub-micron-sized crystals injected by a MESH
device11. Data were phased by molecular replacement using as a
starting model the in vitro structure of proteolytically activated
Cyt1Aa12 (PDB entry: “3ron [10.2210/pdb3RON/pdb]”) deter-
mined by synchrotron crystallography at 100 K. Therefore,
37 residues from the N-terminus and 7 residues from the C-
terminus were missing from the initial model, respectively, cor-
responding to the digested propeptides. Clear residual density
allowed us to build most of these residues (H6-L249) (Fig. 1d). At
the monomeric level, the Cyt1Aa protoxin displays a conforma-
tion overall similar to that of the activated toxin, with two outer
layers of α-helix hairpins, αA/αB and αC/αD, respectively cov-
ering the hydrophilic and hydrophobic sides of a central five-
stranded mixed β-sheet (namely β2-β5-β6-β7-β3; Fig. 1e). Besides
the presence of propeptides, the largest structural differences
between the protoxin and the toxin are observed at the C-
terminus where αF residues display distinct conformations
(Fig. 1e). Additionally, the αC/αD hairpin draws away from the β-
sheet and from helix αE upon activation (Fig. 1e and Supple-
mentary Fig. 2a, b). While these conformational changes are on
the overall subtle, they appear to be concerted at the main-chain
level (Supplementary Fig. 2b). At the side chain level, all residues
assuming different conformations are found on the αC/αD side of
the β-sheet, except D72 (Fig. 1e). In some cases, we observe
conformational changes that maintain an H-bond in place, e.g.
that which tethers the αC/αD hairpin (Q138) to the tip of β2
(E45) (Supplementary Fig. 2c).
In vivo-grown Cyt1Aa protoxin crystals are remarkably
packed, burying 40.1% of surface area at crystal contacts
(5484.2 Å2 out of 13661.2 Å2 of total monomeric areas),
compared with only 13.3% (1252.7 Å2 out of 9405.5 Å2) in
crystals of the activated toxin grown in vitro. Examination at the
unit-cell level reveals that the Cyt1Aa protoxin crystallizes as a
domain-swapped (DS) dimer13 with strands β1 (contributed by
the N-terminal propeptide) and β2 entwined at the DS interface
(interface #1), aligned with a crystallographic two-fold axis
(Fig. 2a, Supplementary Fig. 3 and Supplementary Table 1). The
DS interface of Cyt1Aa, which is mainly stabilized by H-bonds
between carboxylic (E32, E45, D137, E156), amide (Q138, N181)
and amine (R30) groups (Fig. 2b), also includes the αC/αD
hairpin and the C-terminal propeptide helix αF (Fig. 2a), burying
a cumulated surface area of 3077 Å2 in each monomer—i.e.
22.5 % of the protoxin accessible area, which is more than all
other crystal packing interfaces combined (2414 Å2 over nine
interfaces; Supplementary Fig. 3 and Supplementary Table 1) or
all interfaces in the in vitro crystals of the activated toxin
combined (1710 ± 120 Å2) (Fig. 1f). Formation of the DS dimer
thus likely precedes crystallization in Bti cells. A similar DS
interface was previously observed in the in vitro structure of the
homologous non-cytolytic Cyt2Ba protoxin (33% identity with
Cyt1Aa), but its biological significance could not be ascertained14.
Strikingly, residues absent from the activated toxin structure
are the main contributors to the packing of the natural crystals.
Most notably, the N-terminal propeptide buries 73% of its surface
area (2704 over 3691 Å2) across nine interaction zones,
contributing 34 H-bonds, 10 salt-bridges and a disulfide bridge
at position C7 (Fig. 1g). This disulfide bridge is aligned with the
other crystallographic two-fold axis (Fig. 2). Collection of a
dataset upon soaking of crystals with 1 mM DTT (“DTT” dataset)
indicates that at pH 7, rupture of the C7(Sγ)-C7(Sγ), evidenced
by a strong negative peak in the FoDTT, pH7–FopH7 map, is not
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Fig. 1 SFX on in vivo-grown crystals enables determination of the Cyt1Aa protoxin structure. a–c Cyt1Aa sub-micron-sized crystals were grown in vivo
by recombinant expression in Bti-4Q7, and their quality assessed by scanning electron microscopy (SEM; a scale bar= 200 nm), atomic force microscopy
(AFM; b scale bar= 500 nm) and transmission electron microscopy (TEM; c scale bar= 200 nm). d Electron density was visible for the propeptides in the
initial 2Fo-Fc electron density map displayed at 1 σ. The N-terminal propeptide establishes contact with four symmetry-related molecules. e Tertiary
structure of Cyt1Aa. In the right panel, the two chains constitutive of the asymmetric unit of the activated toxin (“3ron [10.2210/pdb3RON/pdb]”) are
overlaid on the protoxin structure, with residues displaying different side chain conformations shown as sticks. Secondary structure information is overlaid
on the models. f Packing in the natural protoxin crystals grown in vivo (left) and in the crystals of the activated toxin grown in vitro (right). g The
N-terminal and C-terminal propeptides scaffold the natural crystals.
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sufficient to prompt crystal dissolution, degrade crystal quality or
induce structural changes within the protoxin (Fig. 2b, Supple-
mentary Fig. 4 and Table 1). Collection of a dataset upon soaking
of crystals in CAPS buffer at pH 10.3 (“pH10” dataset) identifies
the DS interface as the most sensitive to pH elevation, with the
strongest positive and negative peaks in the FopH10–FopH7 map
observed on E32, E45, and Q138 (Fig. 2b and Supplementary
Fig. 4). Refinement of the “pH10” structure confirms changes in
interactions at the DS interface (Fig. 2b and Supplementary
Fig. 2a–e and Supplementary Fig. 4), with loss of H-bonds
between facing monomers (e.g. between E32 and E45 side
chains), as well as within each monomer (e.g. between E45 and
Q138 side chains). As a result, strands β1, β2 and the C-terminal
propeptide concertedly draw away from strand β3, at the opposite
end of the β-sheet, but also from the αC, αD, and αE helices,
which together cover the hydrophobic face of the β-sheet
(Supplementary Fig. 2a–e). The C7 side chain displays two
alternate conformations in the “pH10” structure, respectively
characterized by Sγ–Sγ distances of 2.1 and 3.9 Å, indicating
partial rupture of the disulfide bridge upon elevation of pH to
10.3 (Fig. 2b and Supplementary Fig. 4). Importantly, a positive
peak is seen between D11 and Q168 in both the FopH10–FopH7
and the FoDTT,pH7–FopH7 maps, highlighting that this interface is
sensitive to both reducing agent and pH elevation (Fig. 2b and
Supplementary Fig. 4). The αA/αB face of the β-sheet is not
affected by pH elevation.
We engineered a C7S mutation to probe the role of the
disulfide bridge. By recombinant expression in Bti-4Q7, we
obtained sub-micron-sized crystals diffracting to 2.0 Å resolution,
which revealed a structure nearly indiscernible from the “DTT”
structure (Fig. 3 and Supplementary Fig. 2a–e). Thus, neither
crystal formation nor crystalline order depends on the disulfide-
bridge chaining of DS dimers. This step therefore likely occurs
after the crystal is fully formed. We also mutated the other
residues pinpointed by strong peaks in the Fo–Fo maps, D11,
E32, E45, Q168, and Y171, hypothesizing that they would be
central to crystal formation and dissolution, and possibly function
(Fig. 3). As a control for C7, we mutated the other cysteine of
Cyt1Aa, C190. For all mutants, sub-micron-sized crystals were
obtained by recombinant expression in Bti-4Q7. A full descrip-
tion of our difference-density based mutation strategy is
presented in Supplementary Note 1.
Mapping the role of the disulfide bridge and DS interface. The
Cyt1Aa bioactivation cascade involves dissolution of crystals in
the alkaline environment of the mosquito gut. Accordingly, a pH
of 11.2 ± 1.0 is required to solubilize 50% of Cyt1Aa WT crystals
after 1h incubation (SP50) (Fig. 3 and 4a and Supplementary
Table 2). This incubation time was chosen on the basis that the
transit time along the mosquito larvae gut is 30–60 min,
depending on species15. When DTT is added, crystals solubilize at
a significantly lower pH, with a SP50 of 9.8 ± 1.0 (Fig. 4a and
Supplementary Table 2). The solubilization pattern of C190V
crystals does not significantly differ from the WT, confirming that
this mutation does not affect the pH sensitivity of crystals and
that the effect of DTT on crystal solubilization is unrelated to
C190 (Figs. 3 and 4a). Likewise, the hydrophobic-core Y171F
Table 1 Data collection and refinement statistics (molecular replacement).
Wild type, pH 7 Wild type, DTT Wild type, pH 10 C7S, pH 7
PDB accession code 6T14 6T19 6T1A 6T1C
Data collection
Space group P6122 P6122 P6122 P6122
Cell dimensions
a, b, c (Å) 64.8, 64.8, 164.5 65.6, 65.6, 164.3 65.5, 65.5, 165.5 65.6, 65.6, 164.1
α, β, γ (°) 90, 90, 120 90, 90, 120 90, 90, 120 90, 90, 120
X-ray beam focus (μm) 1.3 1.3 1.3 1.3
Number of collected frames 65473 39547 45117 18218
Number of indexed patterns 8584 18882 20052 7754
Number of merged images 8462 b 18766 b 19924 b 7683 b
Resolution (Å)a 43.5-1.86 (1.89-1.86) 43.5-1.83 (1.86-1.83) 43.5-1.85 (1.88-1.85) 43.5-1.97 (2.01-1.97)
Number of observations 2003832 (16132) 3285436 (30913) 3123781 (30982) 1203324 (23089)
Number of unique reflections 17966 (898) 18261 (1003) 18439 (910) 14420 (877)
I/σ(I)a 18.6 (1.6) 32.8 (3.0) 34.6 (3.2) 19.8 (2.8)
Rsplit (%)a 12.5 (87.7) 7.4 (51.7) 7.0 (49.5) 12.5 (61.6)
CC1/2a 99.5 (7.8) 99.8 (16.4) 99.8 (7.3) 99.4 (17.8)
Completeness (%)a 98.7 (100.0) 99.9 (100.0) 99.9 (100.0) 99.9 (100.0)
Multiplicitya 107.8 (18.0) 160.5 (30.8) 165.4 (33.6) 65.8 (26.33)
Refinement
Resolution (Å)a 1.86 (1.91–1.86) 1.85 (1.90–1.85) 1.85 (1.90–1.85) 2.00 (2.05–2.00)
Number of reflectionsa 16099 (1126) 17339 (1231) 17513 (1262) 13698 (722)
Rwork /Rfreea 0.21.7 (0.503)/0.25.9
(0.451)
0.231 (0.459)/0.295
(0.547)
0.237 (0.497)/0.287
(0.494)
0.220 (0.427)/0.267
(0.473)
Number of atoms
Protein 1923 1941 1987 1941
Water 251 293 281 276
B-factors (Å2)
Protein 30.2 32.6 36.1 35.8
Water 47.7 52.3 48.5 48.0
R.m.s. deviations
Bond lengths (Å) 0.007 0.007 0.007 0.007
Bond angles (°) 1.146 1.083 1.103 1.120
aValues in parentheses are for highest-resolution shell.
bThe number of merged images corresponds to number of crystals used to solve the structure.
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Fig. 2 Disulfide-bridge chaining of domain-swapped (DS) dimers in the natural Cyt1Aa crystals. a Cyt1Aa dimers associated through a DS interface
constitute the building block of natural crystals. These DS dimers are chained one to another by a disulfide bridge at position C7. b Fourier difference maps
computed between datasets, and phased by the pH7 structure, highlight the most striking conformational changes upon pH elevation (upper panels;
Fo[pH10]–Fo[pH7] map) and DTT soak (lower panels; Fo[DTT]–Fo[pH7] map). The difference maps are overlaid on the pH7 protoxin structure, shown as a
slate-colored ribbon. Symmetry related molecules are all colored differently, with each molecule having the same color coding in all panels. From left to
right, the figure shows the maps contoured at ±3 σ around the disulfide bridge, at crystal packing interface #3 and at the DS interface, respectively. Positive
and negative peaks are shown in green and red. Secondary structure information is overlaid on the models.
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mutation does not significantly affect pH sensitivity, eliminat-
ing the possibility of this residue partaking in the crystal dis-
solution mechanism (Fig. 3, Supplementary Table 2 and
Supplementary Fig. 5). In contrast, the C7S crystals dissolve in
the absence of DTT at the same pH as WT crystals soaked with
DTT and remain unperturbed by addition of DTT (Figs. 3 and
4a). Hence, the disulfide bridge contributed by C7 increases the
resilience of WT crystals by diminishing their pH sensitivity.
Likewise, the Q168E mutation strongly increases pH sensitivity
to lower pHs, with SP50 of 10.0 ± 1.0 and 8.5 ± 1.0 in the
absence and presence of DTT, respectively, confirming the
suspected involvement of interface #3 (Fig. 2b, Supplementary
Fig. 4 and Supplementary Table 1) in pH sensing and in the
subsequent dissolution cascade (Fig. 3 and Supplementary
Table 2). Irrespective of the presence of DTT, the D11N, E32Q
and E45Q mutations do not significantly affect pH sensitivity
(Fig. 3, Supplementary Table 2 and Supplementary Fig. 5),
indicating that none of the pH-insensitive H-bonds introduced
by mutation at the DS interface is on its own sufficient to
significantly increase the SP50.
We characterized the first active protoxin unit—i.e., that
released upon crystal dissolution—by combined use of electro-
phoresis and mass spectrometry. By these two methods, we found
that a dimer is predominantly released upon dissolution of
crystals in the absence of DTT, accompanied by a monomer and
by decreasing amounts of 3-mers, 4-mers and 5-mers (Fig. 4b and
Supplementary Fig. 6). The dimer is disulfide-bridged at position
C7, as demonstrated by the fact that it dissociates into monomers
in presence of DTT and β-mercaptoethanol, but not upon heating
to 95 °C, and by the observation of a single monomeric species
upon dissolution of crystals of C7S, but not C190V (Fig. 4b and
Supplementary Figs. 4–7). The observation of WT Cyt1Aa
monomers upon dissolution of crystals in the absence of DTT
nonetheless establishes that a fraction of the disulfide bridges
break upon elevation of pH to 11 (Fig. 4b and Supplementary
Fig. 6), consistent with the two alternate conformations observed
in the “pH10” structure (Fig. 2b and Supplementary Fig. 4) and
with the known pH sensitivity of disulfide bonds which can
rupture upon pH elevation following a Cys-S-S-Cys + OH− →
Cys-S− + Cys-S-OH oxidation reaction16,17. The pH-dependent
heat-stability profile of the Cyt1Aa protoxin dimer is also
consistent with the presence of a disulfide bridge associating
two protoxin monomers in the dimer (Supplementary Fig. 7)18.
Residual dimers persist even at the highest concentrations of DTT
and β-mercaptoethanol tested (200 and 715 mM, respectively),
which likely are steady DS dimers (Supplementary Fig. 8). This
hypothesis would explain the presence, upon dissolution of WT
crystals in the absence of DTT (Fig. 4b and Supplementary
Fig. 6), of higher order oligomers, corresponding to associations
by disulfide bridges of a monomer and a DS dimer (3-mer), or of
two DS dimers (4-mer), or of two DS dimers and a monomer
(5-mer), etc. It would also rationalize the absence of these
oligomers upon addition of reducing agents.
It remains uncertain whether or not the mosquito gut is a
reducing environment19 and thus under what form the protoxin
is mainly released upon crystal dissolution in the natural context.
We found that regardless of whether the protoxin is present in the
form of a disulfide-bridged dimer or a protoxin monomer,
addition of proteinase K, shown to faithfully mimic mosquito gut
proteases20, allows activation into a 23 kDa toxin monomer,
consistent with the cleavage of its first 30 and last 5 amino acids21
(Fig. 4b and Supplementary Fig. 6). Thus, irrespective of the
redox state of the mosquito gut, a 23 kDa monomeric activated
toxin is eventually made available upon activation by gut
proteases. Nonetheless, two other Cyt1Aa species—a disulfide-
bridged dimer (~54 kDa) and a protoxin monomer (~27 kDa)—
could co-exist in the mosquito gut depending on its redox state
(Fig. 4b and Supplementary Fig. 6).
We therefore investigated the propensity of these three Cyt1Aa
species—the disulfide-bridged dimer, the protoxin monomer and
the activated toxin monomer—and of their mutated variants to
assemble into membrane-bound oligomers (MBO). When
monomers of either the 27 kDa protoxin or the 23 kDa
proteolytically activated toxin7,21,22 are mixed with POPC
liposomes (~100 nm radius) and electrophoresed on 6% SDS-
PAGE gels, a ladder pattern characteristic of Cyt1Aa MBO is
observed (Fig. 4c). The disulfide-bridged dimer is unable to form
MBO upon contact with liposomes (~100 nm radius; LUVs)
whereas the C7S mutant, able only to solubilize as protoxin
monomers, forms MBO regardless of proteolytic activation (Fig. 3
Cyt1Aa mutant Wild-type C7S C190V Y171F D11N Q168E E32Q E45Q
Crystal shape (SEM)
Crystal size (in
nm) (mean ±
SE)
L1
–DTT5
+DTT6
–DTT5
+DTT6
+DTT6
Act.7
Act.7
925.0 ± 28.3a
11.18 ± 1.01ab
366.9 ± 1.9a
84.7 ± 1.8a 76.5 ± 2.0a 94.2 ± 1.8a
460.7 ± 1.6a 301.9 ± 1.4a 610.7 ± 1.6a
105.9 ± 1.7a >30,000
>30,000
101.1 ± 1.9a
293.4 ± 1.8a
9.58 ± 1.02c 11.07 ± 1.01ab 10.90 ± 1.02ab 10.87 ± 1.01a 9.95 ± 1.01c 11.31 ± 1.02ab
3676.0 ± 1.5b >30,000
204.7 ± 1.3b 1156.9 ± 1.1
b
11.38 ± 1.01b
9.94 ± 1.02a9.80 ± 1.02a8.46 ± 1.02c9.22 ± 1.02b9.50 ± 1.02ab9.71 ± 1.01ab9.63 ± 1.02ab9.78 ± 1.01ab
No
Yes
Yes No
Yes Yes
Yes Yes
No
Yes
Yes
No No
No
No
No
No
No
No
No
Yes
Yes
YesYes
746.6 ± 16.8b 666.8 ± 17.5b 751.6 ± 14.6b 1217.2 ± 36.4c 1086.7 ± 26.6d 894.9 ± 20.7a
619.5 ± 13.8a
1.44 ± 0.14a
1153.4 ± 20.8cd
768.0 ± 15.6d
1.51 ± 0.12a
588.2 ± 18.6a 601.1 ± 13.2a
1.81 ± 0.16e2.09 ± 0.27d
482.9 ± 8.5c
1.56 ± 0.14ac
402.5 ± 8.7b
1.66 ± 0.13c
612.4 ± 9.4a
1.22 ± 0.13b
591.2 ± 17.3a
1.57 ± 0.15ac
++ ++ ++ ++ +++ +++ +
W2
L/W
Productivity3
Solubility at 1 h
(SP50 ± SE)
4
Toxicity (in nM)
(LC50 ± SE)
9
Oligomer
formation8
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and Supplementary Fig. 9). Thus the disulfide bridge, but not the
N-terminal propeptide, can abrogate MBO formation. Thin layer
chromatography (TLC) nonetheless indicates that the N-terminal
propeptide masks half of the lipid binding interface in the
oligomers, with protoxin and toxin MBO respectively featuring
~11.1 ± 2.6 (N= 4) and ~22.1 ± 6.9 (N= 4) phospholipids per
Cyt1Aa monomer (Fig. 4d), consistent with previous estimations
based on liposome disruption assays23. MBOs do not form upon
contact of toxins with lipids solubilized in detergent micelles or
bilayered in two-times smaller liposomes (~50 nm radius; SUVs)
(Fig. 4c), demonstrating a requirement for a fully formed
membrane with a minimal radius of curvature. MBO persist
after solubilization of their supporting liposomes and, despite an
apparent spacing of bands by 11–17 kDa in SDS-PAGE gels
(Supplementary Fig. 10), dissociate into full-size monomers upon
heating to 95 °C (Fig. 4d and Supplementary Fig. 6). This
observation shows not only that MBO formation entails drastic
conformational changes after which Cyt1Aa may not solubilize as
a monomer unless heated, but also that there is no further
proteolytic cleavage occurring post-insertion into membrane nor
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covalent link between monomers within MBO. MBO formation is
unaffected by the C190V and Y171F mutations but is reduced in
the E32Q protoxin and abrogated in the E45Q and Q168E
protoxins, with full, partial and no restoration upon cleavage of
the propeptides, respectively (Fig. 3 and Supplementary Fig. 9).
This result indicates that stabilization of the N-terminal
propeptide, and by extension of the DS dimer, inhibits MBO
formation. That propeptide removal does not rescue MBO
formation in E45Q and Q168E indicates that these mutations
further impact processes downstream dissociation of dimers into
monomers.
Treatment of Cyt1Aa MBO with detergents other than SDS
(sodium dodecyl sulfate) prior to electrophoresis on native gels
reveals the unique ability of SDS to produce a ladder pattern,
effectively breaking down higher order MBO as they migrate
through the gel (Supplementary Fig. 11). The smallest and largest
MBO fragments migrate at the expected sizes for a Cyt1Aa trimer
and 26-mer (~0.6 MDa; Fig. 4c), respectively, but cross-linking
(using either glutaraldehyde or DTSSP (3,3′-dithiobis(sulfosucci-
nimidyl propionate)) thence affording 3 and 12 Å spacing
between amines, respectively) prior to SDS-PAGE migration
prevents MBO from entering gels, suggesting that they are
natively larger (Supplementary Fig. 12). We note that similar
ladder-like profiles, proposed to reflect formation of oligomers of
non-fixed stoichiometry by stepwise addition of monomeric
units7 have been reported for the structurally homologous
Cyt2Aa24,25 and VVA226 toxins, as well as for pneumolysin27,
whose pore-forming domain resembles Cyt1Aa28.
Cytotoxicity originates from MBOs. Cyt1Aa WT toxicity was
assayed on insect Sf21 cells (0.04–0.4 μM) (Supplementary
Fig. 13, Supplementary Movies 1 and 2) and on two mammalian
cell lines, namely NIH fibroblast cells (0.04–4 μM) (Supplemen-
tary Fig. 13, Supplementary Movies 3 and 4) and HEK293 cells
(0.001–30 μM) (Figs. 3 and 4e and Supplementary Table 2),
supporting a generalist mode of action whose efficiency likely
depends on the cell membrane phospholipid composition.
HEK293 cells were chosen to pursue investigations, because their
monodisperse nature enables use of a fluorescence-activated cell
sorting (FACS) flow cytometer system, combined with propidium
iodide (PI) staining as a reporter for cell death, to quantify the
cytotoxicity of WT Cyt1Aa and mutants thereof. For each, LC50
values were determined in the disulfide-bridged dimer (except
C7S), protoxin monomer, and activated monomer forms (Fig. 3
and Supplementary Table 2).
All mutants and/or toxin forms capable of yielding MBO also
display cytotoxicity (Figs. 3 and 4e–g and Supplementary Figs. 9
and 14), illuminating a direct link between MBO formation and
cytotoxicity. Briefly, we found a four-fold increased toxicity for
the activated toxin (LC50= 0.085 μM) when compared to the
monomeric protoxin (LC50= 0.36 μM), which could stem from
the reduced interaction surface for phospholipids on the protoxin
(Figs. 3 and 4e). Contrastingly, the disulfide-bridged dimer
exhibits a ~200 fold lower toxicity (LC50= 16.6 μM) (Figs. 3 and
4e) which, given the inability of this dimer to form visible MBO
on SDS-PAGE gels (Fig. 4c), could be due to residual monomers
present in the sample (Fig. 4b and Supplementary Fig. 6). The
C7S, C190V and Y171F mutants, which form MBO, display the
same toxicity as the WT (Fig. 3, Supplementary Fig. 14 and
Supplementary Table 2), excluding a possible role for these
residues in cytolytic oligomer formation. Addition of DTT to
proteolytically activated WT, C7S and C190V Cyt1Aa does not
significantly change cytotoxicity (LC50= 0.112 μM), further
demonstrating that neither cysteine is involved in the formation
of Cyt1Aa cytolytic oligomers and eliminating a DTT effect on
toxicity (Figs. 3 and 4e–g and Supplementary Table 2). In
contrast, cytotoxicity is affected in all but one of the DS and
interface #3 mutants, mirroring their inability or reduced ability to
form MBO. The E32Q mutant shows a 10 and 2.4 fold reduced
toxicity in the protoxin and toxin forms compared to WT,
respectively, suggesting that the mutation inhibits the transition
into an MBO conformer (Fig. 3 and Supplementary Fig. 14). The
E45Q mutant shows no toxicity in the protoxin form (up to
30 μM) and a 14-fold reduced toxicity upon proteolytic activation,
indicating that in addition to inhibition of the transition into an
MBO conformer due to stabilization of the DS dimer by H-
bonding to E32, the pH-desensitization of the β2 (E45Q) tether to
the αC/αD hairpin (Q138) blocks another important step in the
formation of cytolytic oligomers (Fig. 3 and Supplementary
Fig. 14). Most strikingly, the Q168E mutation eliminates
cytotoxicity of both the protoxin and the activated toxin (up to
30 μM), again paralleling the inability of these to form MBO
and suggestive of Q168 being involved in the interaction with—
and possibly the perforation of—cell membranes (Fig. 3 and
Supplementary Fig. 14). Interestingly, the reverse mutation D11N
does not significantly affect toxicity, clearly splitting the different
roles played by Q168 in crystal formation and dissolution, and in
cytotoxicity (Fig. 3 and Supplementary Fig. 14).
Porous oligomers fully perforate cell membranes. How Cyt1Aa
exerts its cytolytic activity remains unclear. It has been proposed,
based on electrophysiology data, that Cyt1Aa oligomerizes into
cation-selective channels of 6–20 Å diameter5, but we failed to
observe the formation of such pores despite conducting similar
black lipid membrane (BLM) experiments at Cyt1Aa concentra-
tions ranging from 1.7 to 60 μg mL−1 (Fig. 5a). Rather, our
observations are suggestive of a cooperative membrane-binding
process, whereby multiple toxins successively insert and co-
aggregate in the bilayer (inducing flickering in the measured
electrical current) before the latter is ripped apart3. We therefore
further challenged the porous nature of MBO by exposing Sf21
(insect) (Fig. 5b) and NIH 3T3 (mammal) cells (Fig. 5c) simul-
taneously to Cyt1Aa toxin at sub-lethal concentration and to
fluorescent dextran beads of 1.4–8.5 nm. We found that beads up
to 8.5 nm can penetrate cells through Cyt1Aa-induced
lesions, excluding the possibility that Cyt1Aa forms a selective
pore.
We used AFM on supported lipid bilayers (SLB) to obtain
further insights into the large-scale structural dynamics of
Cyt1Aa MBO (Fig. 5d and Supplementary Fig. 15). Minutes after
the addition of Cyt1Aa WT activated toxin, a first type of MBO—
hereafter referred to as membrane-bound aggregates (MBA)—
forms from the continuous encounter of monomers freely
diffusing at the membrane surface (Fig. 5d–f), with a strong
significant positive correlation between the time elapsed since
toxin addition and the surface area occupied by the MBA
(Fig. 5g). Toxin aggregation eventually leads to the formation of
holes at the periphery of MBA (Fig. 5h, i), consistent with cell
microscopy assays (Fig. 5b, c).
We monitored the area occupied by MBA and holes as a
function of hole depth. The significant negative correlation
observed between the hole depth and MBA surface (Fig. 5j), but
not between the hole depth and the total “MBA+hole” surface
(Fig. 5k), suggests that two types of MBO coexist: porous
oligomers and MBA. Full membrane perforation is visible only
for holes of ~54 nm diameter, with a ~2300 nm² surface and
~169 nm circumference, corresponding to a porous oligomer
formed by the assembly of ~56 monomers (Fig. 5j). That only a
fraction of the porous oligomers displays sufficient depth to fully
perforate the membrane (~4.5 nm) suggests that the structural
transition between MBA and porous oligomers is independent of
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MBA size and could involve formation of a pre-pore (Fig. 5j).
Experiments on the Q168E mutant reveal that this mutation
affects the first step of toxin insertion into the membrane. Indeed,
the Q168E mutant is unable to penetrate the membrane and
aggregate to form pores (Fig. 5l), behaving like the BSA control
(Fig. 5m).
We attempted to characterize the porous oligomers by TEM,
either after negative staining or under cryogenic conditions (cryo-
EM). Addition of Cyt1Aa to 100 nm liposomes led to their almost
total disruption, with the few remaining LUVs exhibiting
membrane leakage (Fig. 5n), and to the release of a homogenous
population of 3.50 ± 0.42 nm thick and 30.3 ± 2.3 nm long
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Fig. 5 Cyt1Aa forms oligomers that fully perforate and eventually disrupt lipid bilayers. a Single cation-channel formation was not observed in black lipid
membrane (BLM) experiments. b, c Cyt1Aa allows entry in both Sf21 (b) and NIH 3T3 cells (c) of co-incubated FITC-labelled (fluorescein isothiocyanate)
dextran beads up to 8.5 nm in size. Scale bars= 10 µm. d–f Membrane-bound Cyt1Aa monomers exhibit mobility (d, e) and display the capacity to merge
into larger membrane-bound aggregates (MBA). Scale bars= 3 µm (d) and 300 nm (e, f). g A significant positive correlation was observed between the
surface of MBA and the time elapsed since toxin addition. h 35min after toxin addition, membrane perforation is observed at the periphery of MBA. Scale
bar= 500 nm. i The depth of holes can reach 4.5 nm, consistent with a full spanning of the lipid bilayer. j, k A significant negative correlation is observed
between the surface of holes and their depth (j), but not between the latter and the combined area of the hole and the parent MBA (k). l, m Formation
of MBA and holes was neither observed for the activated form of the non-toxic Q168E mutant (l) nor for the BSA control (m). Scale bars= 500 nm.
n–q Transmission electron microscopy captures liposome lysis by the toxin (n), and the resulting release of arciform oligomers (o–q). Scale bars= 50 nm
(n, q), 20 nm (p) and 100 nm (o). Source data are provided as a Source Data file.
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interface, which allows both self-inhibition and in vivo crystallization, and ends with oligomer formation in the membrane of mosquito gut cells. The Cyt1Aa
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arciform oligomers, characterized by a mean curvature of 129.3 ±
7.4° (mean ± SD; N= 27) (Fig. 5n–q). These could represent
either the open form of a porous oligomer or pieces thereof. In
the first case scenario, i.e. assuming conservation of the length of
arciform oligomers, porous oligomers would be ~12 mers of
~276 kDa characterized by a 2–5 nm pore, which is inconsistent
with our native and SDS-PAGE, AFM and BLM conclusions.
Thus, we favor the hypothesis that arciform oligomers represent
pieces from the breakdown of larger cytolytic oligomers, such as
those observed by AFM.
Discussion
Structural investigations of in vivo-grown sub-micron-sized
crystals using SFX, AFM, and complementary methods have
shed light on key steps in the Cyt1Aa bioactivation cascade, from
in vivo crystallization in Bti cells, to crystal dissolution, proteo-
lytic activation, and membrane insertion and perforation through
oligomerization (Fig. 6). Our SFX structures point to the N-
terminal propeptide of Cyt1Aa being a key structural element
which, by dimerization through a DS interface13,14, intervenes in
Cyt1Aa folding, self-inhibition and in vivo crystallization—but
not in crystal dissolution. Rather, we unveil the respective roles
played by the disulfide-bridge and interface #3, showing how
these act together to ensure crystal dissolution occurs only under
highly alkaline (and possibly reducing) conditions, such as those
found in the larval mosquito midgut. This mechanism differs
slightly from that highlighted in naturally occurring nanocrystals
of BinAB, wherein no cysteine interface is in play and it is rather
pH-induced electrostatic repulsion at crystal interfaces between
tyrosine residues and their obligate H-bond acceptors that com-
plements the analogous mechanism between acidic side chains29.
Further structural characterization of naturally crystalline pro-
toxin structures may allow the discovery—and eventually the
utilization—of additional mechanisms of in vivo crystallization
and controlled pH-dependent solubilization.
It remains unclear whether the mosquito gut is a reducing
environment19. If so, crystals could dissolve and begin to initiate
cytopathology at a pH as low as 9.5, in line with the observation
of Cyt1Aa lesions to anterior midgut cells30; if not, a disulfide-
bridged dimer would be released upon crystal dissolution, which
would need to be proteolytically activated. We showed that both
this dimer and the protoxin monomer can be processed by pro-
teases, yielding the 23 kDa activated toxin. We also show that
upon contact with a lipid membrane, drastic conformational
changes take place, most likely due to an opening of the structure
at the αC/αD hydrophobic interface with the β-sheet. This
interface indeed demonstrates the greatest structural differences
observed between the protoxin at pH 7, the protoxin at pH 10
and the activated toxin at pH 8 (Figs. 1 and 2, and Supplementary
Figs. 2–4). The hypothesis that an opening of the protein at the
αC/αD hydrophobic interface is required for MBO formation was
examined by the introduction of a E45Q mutation, intended to
render pH-insensitive the tether between the β-sheet and αD
(Q138(OE1)), besides stabilizing the DS dimer. The mutation
favoured crystal growth but resulted in a 14-fold reduced toxicity
for the activated toxin, while eliminating toxicity of the protoxin
(Fig. 3). It thus seems plausible that opening of the WT structure
at the αC/αD hydrophobic interface with the β-sheet is an
important step for membrane insertion and subsequent MBO
formation. That the αC/αD hairpin would be involved in MBA
formation is in line with its burial at the DS interface in the
protoxin structure.
Evidence was also provided that Q168, buried at crystal
packing interface #3, is a key player in crystal formation (mark-
edly different crystal dimensions and production yield upon
Q168E mutation), pH-induced dissolution (~1 pH unit difference
upon Q168E mutation) and toxic activity (fully abrogated in the
Q168E mutant) (Fig. 3). AFM imaging and SDS-PAGE analyses
indicate that the mutation produces effects at the membrane
insertion level, which we interpret as an indication that this
residue, at the tip of β5, is part of the β-sheet structure that
plunges into the membrane to form the porous oligomer. This
proposition is in agreement with earlier mass spectrometric
determination of the extent of membrane-inserted domains in the
Cyt1Aa porous oligomers31. These studies indeed pointed to
residues 42 to 132 forming the hydrophilic part of the pore (β2-
αA-αB-β3), and to residues 154 to 234 as being membrane-
associated and thus forming the hydrophobic part of the pore.
These are all residues located between the C-terminus of αD and
the N-terminus of αF (Fig. 1), namely the αD-β4 loop and the β4-
β5-β6-β7 β-sheet featuring the short αE helix between β6 and β7.
It was also shown that the N- and C-termini of the protein
are both exposed on the extracellular side of the pore31,32.
The simplest way to reconcile these two results is to envision a
pore wherein β4 (and possibly the αD-β4 loop) contributes one of
the strands of the oligomerizing β-sheet structure, with the β4-β5
loop pointing on the intracellular side—in line with our proposal
that Q168 is part of the β-sheet structure that plunges into the
membrane. Regardless, the absence of β2 and β3 from the
membrane-inserted segment of the pore31 indicates that these
must respectively dissociate from β4 and β7 on each edge of the
β-sheet, to enable transition to the porous oligomer. It remains to
be determined if this step is completed at the monomer to MBA-
conformer (i.e. upon interaction with the membrane) or at the
MBA-conformer to porous oligomer transition (i.e. upon side-by-
side contact between MBA conformers).
The exact structures of the Cyt1Aa MBA conformers and
porous oligomers remain to be determined. Our CryoEM results
revealed arciform oligomers from which a high resolution
structure could not be derived. CryoEM investigations on pneu-
molysin33, whose pore-forming domain resembles Cyt1Aa28 and
which alike Cyt1Aa yields ladder-like profile on SDS-PAGE gels27
and arciform oligomers upon insertion into liposomes34,35, sug-
gest that a prerequisite to obtaining a high resolution cryoEM
structure of Cyt1Aa porous oligomers will be to carefully devise a
lipid/detergent/additive formulation capable of stabilizing their
annular architecture, i.e. preventing their fall-off into arciform
oligomers. At present, we can nonetheless propose a model that
fits all the information developed by us and others on Cyt1Aa
pore formation2–6,21,27,31,36 (Supplementary Fig. 16). Our AFM,
BLM, TEM and in vivo cell assay data exclude the possibility that
Cyt1Aa exerts toxicity by forming a cation-channel of 6–20 Å
diameter (the “pore-forming” model)4–6, or by acting as a
detergent with molecules bound to—but not inserted into—the
membrane, (the “detergent-like” model)2,3. Rather, the data taken
together suggest that following the untethering of the αC/αD
hairpin from the β-sheet due to pH elevation and proteolytic
activation, the Cyt1Aa structure opens at this locus upon mem-
brane contact, yielding a new membrane-bound Cyt1Aa con-
former—the MBA conformer. Side-by-side contact between the
β-sheets of adjacent MBA protomers would enable the observed
transition to the porous conformation. Our data show that this
cooperative MBA-to-porous conformer transition occurs only
after a critical number of molecules is recruited, yielding the
observed >54 nm diameter membrane perforation upon con-
comitant plunging across the bilayer of the β-sheets of ~56 or
more associated porous conformers (Figs. 5 and 6)—possibly with
their β4-β5 loops and αE helices pointing towards the intracel-
lular side31,36. Importantly, this proposed model reconciles the
data hitherto presented to oppose the “pore-forming” and
“detergent-like” models2,3, e.g. explaining how the N-terminal
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and C-terminal parts of the toxin can both be exposed on the
outer face of the membrane31,36; how can the membrane-inserted
segment of porous oligomers feature Cyt1Aa residues spanning
αD to αF31,36; how the large pores formed by Cyt1Aa can enable
transit into midgut cells of large molecules or proteins, such as
the 42 kDa BinA toxin30; how the non-porous Cyt1Aa oligomers,
here identified as MBA, may serve as substitutes for mosquito
receptors of Cry toxins, enabling them to dock on mosquito
midgut cell membranes and subsequently assemble into toxic
pores even in absence of their specific membrane-bound recep-
tors. Lack of expression of toxin receptors, or expression of
defective or soluble variants thereof, is indeed one of the most
efficient mechanisms developed by insects to resist Bt toxins37,38.
We admittedly leave open the question of the exact structure of
Cyt1Aa porous oligomers, with hope that high resolution cryoEM
structures of the Cyt1Aa porous oligomer and/or MBA con-
formers may soon shed further light on the issue.
Besides clarifying our understanding of the Cyt1Aa bioactiva-
tion cascade, our study provides insights into how the yield
(D11N, E32Q), toxic function (E45Q, Q168E) and pH sensitivity
of Cyt1Aa crystals (C7S, Q168E) can be curbed by single atom
substitutions, opening avenues to exploit recombinant Cyt1Aa
variants as improved mosquitocides with increased production
yield, extended target spectrum and improved toxicity. Results
furthermore push SFX and our difference-density based mutation
strategy forward as means to obtain structural and functional
insights into naturally crystalline insecticidal proteins.
Methods
Plasmid construction, crystal production, and purification. The shuttle vector
pWF45 was used to produce in vivo crystals of wild-type Cyt1Aa toxin8,39. It was
also used as a backbone to construct plasmids containing single-point mutated
cyt1aa genes. A total of 7 point-mutants of Cyt1Aa were constructed based on the
difference-density maps generated from crystallographic data (Fig. 2 and Supple-
mentary Fig. 4). A detailed description of the mutation strategy is available in
Supplementary Note 1. Our extensive analysis of the bibliography indicates that
none of these mutants has been constructed in previous studies (Supplementary
Table 3 and Supplementary Fig. 16).
Point mutations were inserted into cyt1aa gene sequence by Gibson assembly
(the list of primers used for plasmid construction is available in Supplementary
Table 4). For each mutant, two fragments were amplified from pWF45 using two
different primer couples. The fragments were complementary by their 15–18 bp
overlapping 3′ and 5′ overhangs with a target Tm of 50 °C. The point mutation was
inserted into the overhangs of the two fragments spanning the cyt1aa gene. For
each mutant, the two fragments were assembled using the NEBuilder HiFi DNA
Assembly (New England BioLabs) by following manufacturer’s instructions. After
90 min of incubation at 50 °C, the constructed plasmids were transformed by the
heat shock procedure into chimiocompetent Top10 Escherichia coli strain (New
England BioLabs). Colonies were selected on LB agar medium supplemented with
ampicillin (100 μg mL−1) and plasmids were extracted by using the NucleoSpin
Plasmid extraction kit (Macherey-Nagel). Successful plasmid constructions were
validated by double digestion (EcoRI and BamHI) followed by migration on 1%
agarose gel stained with SYBR Safe (Invitrogen) and presence of mutations was
assessed by Sanger sequencing at the Eurofins Genomics sequencing platform.
Validated plasmids were transformed into the acrystalliferous strain 4Q7 of
Bacillus thuringiensis subsp. israelensis (Bti; The Bacillus Genetic Stock Center
(BGSC), Columbus OH, USA) with an improved electrotransformation
procedure40 using a MicroPulser Electroporator (BioRad). Colonies were selected
on LB agar medium supplemented with erythromycin (25 μg mL−1) and used to
inoculate an overnight 5 mL LB liquid preculture. Precultures were spread on
T3 sporulation medium and incubated at 30 °C for 4 days to promote Bti
sporulation and toxin crystal production. Spores and crystals were collected using a
cell scraper, resuspended in water and centrifuged once at 10,000 g for 45 min. The
pellet was resuspended in water and purified using a discontinuous sucrose
gradient (67-72-79%). After 16h of ultracentrifugation at 23,000 g and 4 °C, the
crystals were recovered from the 67–72% interface. Several rounds of centrifugation
and resuspension in water were performed to discard as much sucrose as possible.
Crystal purity was verified by SDS-PAGE on 12% gels. Purified crystals were
conserved in ultrapure water at 4 °C until use.
Crystal visualization by SEM. For crystal visualization by SEM, crystals were
resuspended in a 25 mM ammonium acetate solution, deposited on microscope
circular glass slides and left for drying under a Sorbonne hood for 1 h or more.
Samples were coated with a 2 nm thick gold layer with the Leica EM
ACE600 sputter coater and imaged using the Zeiss LEO 1530 scanning electron
microscope (SEM). From exported TIFF images, the length and width of crystals of
Cyt1Aa WT and all mutants were measured using the software ImageJ v1.51k
(N= 40 crystals)41. Normality of data was confirmed by a Shapiro–Wilk test.
Differences in length, width and length/width between Cyt1Aa WT and the dif-
ferent mutants were tested with an ANOVA test followed by a post-hoc Tukey
HSD test performed using software R v3.5.242.
Crystal visualization by AFM. For crystal visualization by AFM, 5 μL of purified
Cyt1Aa crystals conserved in ultrapure water were deposited on freshly cleaved
mica without any further treatments and deposited in a desiccation cabinet
(Superdry cabinet, 4% relative humidity) for 30 min. Imaging was performed on a
Multimode 8, Nanoscope V (Bruker) controlled by the NanoScope software
(Bruker, Santa Barbara, CA). Imaging was done in the tapping mode (TAP) with a
target amplitude of 500 mV (about 12 nm oscillation) and a variable setpoint
usually around 70% amplitude attenuation. TESPA-V2 cantilevers (k = 42 Nm−1,
Fq = 320 kHz, nominal tip radius= 7 nm, Bruker probes, Camarillo, CA, USA)
were used and images were collected at ~1 Hz rate, with 512 or 1024 pixel sam-
pling. Images were processed with Gwyddion43, and if needed stripe noise was
removed using DeStripe44.
Crystal preparation and injection via MESH-on-a-stick. SFX experiments were
performed at the Coherent X-ray Imaging (CXI) instrument of the Linac Coherent
Light Source (LCLS) at the SLAC National Accelerator Laboratory of Stanford
University (California, USA). Crystals of Wild-Type (WT) Cyt1Aa (“pH7” dataset)
and of the C7S mutant (“C7S” dataset) were suspended into spin buffer (MES
0.1M, NaCl 0.1M, Glycerol 50%, pH 6.5) and delivered across the X-ray beam at a
concentration of 1.6 % (grams of crystals in 100 mL of buffer solution) in the SCC
sample-chamber at room temperature and under vacuum, using the microfluidic
electrokinetic sample holder (MESH) method, described more fully in Sierra
et al.11. Cyt1Aa WT crystals were also injected in (i) spin buffer supplemented with
1 mM of freshly prepared DTT, to investigate the structural effects of disruption of
disulfide bonds between N-terminal propeptides—“DTT” dataset; and in (ii) an
alkaline spin buffer (CAPS 0.1M, NaCl 0.1M, Glycerol 50%, pH 10.3) for 6 h
30 min prior to injection to characterize the structural changes that drive crystal
solubilization at high pH—“pH10” dataset. These redox and pH conditions were
chosen after verification that crystals do not dissolve on the timescale of hours.
Specific to MESH injection, a continuous 1.5 m long polyamide-coated fused-
silica capillary of 100 μm inner diameter and 360 μm outer diameter was used to
deliver the sample into the SCC vacuum chamber. Approximately 800 μL of sample
slurry with glycerol additive was pipetted in a microcentrifuge tube, which was then
placed in a small pressurized sample holder. The capillary and the platinum wire
used as an electrode were fed through the pressure cell and immersed in the slurry.
A low backing pressure of 5 psi nitrogen gas was applied in the sample holder to
aid the injection. The voltage was applied by a Stanford Research Systems PS350
(Sunnyvale, CA) high voltage source and was held between 4300 and 4500 V
(currents < 1 μA) while the counter electrode was grounded. The flow rate was not
directly measured, but we estimate that the sample consumption was
approximately 2 μLmin−1, as judged from crude measurements of leftover sample
volume. The four structures presented herein were collected in less than 12 h of
continuous beamtime and consumed less than a milliliter of sedimented crystals.
Data collection and processing, and structure refinement. Datasets were col-
lected with a XFEL beam focused to a 1.3 μm FWHM spot and characterized by a
wavelength of 1.28 Å (proposals P125 and P141). The sample chamber was at room
temperature, under vacuum. We attempted to index all collected images with
DIALS45, using the cctbx.xfel graphical user interface46,47. The final “pH7”, “DTT”,
“pH10” and “C7S” datasets, respectively, consisted of 8462, 18766, 19924, and 7683
indexed patterns. Data were merged using cxi.merge48, with negative intensities
included, and resolution cut-offs were determined based on completeness (>99%),
redundancy (>60) and CC1/2 (>0.05); in all datasets, <I/sigI> in the highest reso-
lution shells are greater than 2.8. We phased the pH7 dataset by molecular
replacement with Phaser, using as a starting model the activated structure of
Cyt1Aa (“3ron [10.2210/pdb3RON/pdb]”12). Missing propeptide residues were
manually rebuilt based on the electron density. The three other structures were
phased by rigid-body refinement, using as a starting model the pH7 structure.
Further refinement consisted in iterative cycles of manual rebuilding in real space
using Coot49, and refinement in the reciprocal space using Refmac50. In the final
structures, the percentage of residues in the favoured, allowed and outlier regions of
the Ramachandran plot and the clash-score and Molprobity scores are 98.35, 1.65,
0.0, 3.89, and 1.37 for the “pH7” structure (6T14; [10.2210/pdb6T14/pdb]); 98.75,
1.24, 0.0, 5.38, and 1.67 for the “DTT” structure (6T19; [10.2210/pdb6T19/pdb]);
98.35, 1.65, 0.0, 4.51, and 1.75 for the “pH10” structure (6T1A; [10.2210/pdb6T1A/
pdb]); and 99.17, 0.83, 0.0, 2.05, and 1.36 for the “C7S” structure (6T1A; [10.2210/
pdb6T1C/pdb]). Data collection, processing, and refinement statistics are shown in
Table 1. We obtained experimental insights into pH and redox induced con-
formational changes by calculating structure factor amplitude Fourier difference
maps (Fo–Fo) between the “pH7”, “DTT”, “pH10” and “C7S” datasets. To improve
the estimate of structure factor amplitude differences, Fo–Fo maps were q-weighted
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as described51 and produced using a CNS52 custom-written script53. Application of
the q-weighting scheme to the diffraction datasets was essential to eliminate noise
and amplify the difference signal. Fourier difference maps and difference distance
matrix (DDM) calculations were performed using custom-written scripts.
Crystal solubilization assays. To assess the stability of the crystals formed by
Cyt1Aa WT and its different mutants, we determined at which pH the crystals
solubilize (Figs. 3 and 4a and Supplementary Fig. 5). Crystal suspensions were
centrifuged at 11,000 g for 2 min and the pellets were resuspended in 50 μL of
0.1 M of Na2CO3–NaHCO3 solutions buffering at pH ranging from 9.0 to 11.8, or
of Na2HPO4-NaH2PO4 solutions buffering at pH ranging from 8.5 to 9.0, following
guidelines from the Sigma Aldrich Buffer Reference Center. Crystals were exposed
for 1 h at RT in duplicates at each pH and then centrifuged at 11,000 g for 2 min.
The supernatant was promptly and carefully collected. The concentration of
solubilized toxin was quantified using a Nanodrop 2000 (Thermo Fisher Scientist)
by measuring the OD at 280 nm and by using the molar extinction coefficient and
toxin size (27055M−1 cm−1 and 27.3 kDa, respectively, as calculated with the
ProtParam tool of ExPASy (https://www.expasy.org) using the Cyt1Aa protein
sequence available under accession number “Q7AL78 [https://www.uniprot.org/
uniprot/Q7AL78]”). Data are presented as the percentage of solubilization, calcu-
lated by dividing the protein concentration measured at a given pH by that
measured at pH 11.8. For statistics, the best fitted model for the data was selected
among four logistic regression models for binomial distribution (logit, probit,
complementary log–log transformation (cloglog) and Cauchy distribution) by
comparing their deviance using a script modified from54 to calculate for each toxin
the SP50 (pH leading to solubilization of 50% of crystals). 95% confidence intervals
(CI) were calculated with a Pearson’s chi square goodness-of-fit test implemented
in the software R 3.5.242,54. Differences in SP50 between mutants were considered
significant when 95% CI did not overlap55.
Determination of the different forms of Cyt1Aa. We investigated the three
Cyt1Aa species possibly formed, in the mosquito larvae gut, upon dissolution of
crystals and dissociation at the DS interface (namely, the disulfide-bridged dimer),
possible reduction of disulfide bridges (namely, the protoxin monomer) and acti-
vation by proteolysis (namely the activated monomer) (Fig. 4b, Supplementary
Fig. 6). Crystals of WT Cyt1Aa and of all mutants were solubilized for 1h at RT in
0.1 M Na2CO3 buffer pH 11.8 and then were centrifuged at 11,000 g for 1 min. The
supernatant contained the solubilized protoxins (condition 1). Addition of DTT
allowed the breakage of disulfide bonds between protoxin units, if any (condition
2). Soluble protoxins were activated into toxins by the addition of proteinase K or
trypsin (condition 3). For further experiments, toxin was activated by proteinase K
rather than other enzymes, such as trypsin, as it was shown to better mimics the
activation performed by gut enzymes in insects20,21. The different forms of Cyt1Aa
were analyzed by two methods: SDS-PAGE and MALDI-ToF.
For SDS-PAGE experiments, unheated samples were electrophoresed on 12%
SDS-PAGE gels after addition of Laemmli buffer devoid of DTT. After staining by
overnight incubation in InstantBlue (Sigma Aldrich, France), gels were washed
twice in ultrapure water and migration results were digitalized using a ChemiDoc
XRS+ imaging system controlled by Image Lab software version 6.0.0 (BioRad,
France).
MALDI-ToF mass spectra were acquired on an Autoflex mass spectrometer
(Bruker Daltonics, Bremen, Germany) operated in linear positive ion mode.
External mass calibration of the instrument, for the 10–70 kDa m/z (mass/charge)
range, was carried out using a protein calibration standard II from Bruker
Daltonics. All samples were prepared as described above, except for experiments
carried out directly on Cyt1Aa crystals, which involved dissolution of crystals in a
70:30 acetonitrile/water mixture. All Cyt1Aa samples were mixed in variable ratios
(1:5, 1:10 or 1:20, v:v) with sinapinic acid matrix (Sigma; 20 mgmL−1 in water/
acetonitrile/trifluoroacetic acid, 70/30/0.1, v/v/v) to obtain the best signal-to-noise
ratio spectra. 1–2 μL of the mixture was deposited on the target and allowed to air
dry. Mass spectra were acquired in the 10–160 kDa m/z range and data processed
with the Flexanalysis software (v.3.0, Bruker Daltonics).
Heat stability of protoxin. The stability of WT Cyt1Aa protoxin dimers was
assayed at different pH and increasing temperatures (Supplementary Fig. 7).
Crystals of Cyt1Aa WT were solubilized in 0.1 M Na2CO3 buffer pH 11.8, cen-
trifuged and the supernatant containing soluble protoxin dimers was collected.
Suspensions were diluted 50 times in buffers at different pHs. Na2CO3–NaHCO3
buffer solutions (0.1 M) were used for pH 9, 10, and 11, and Na2HPO4–NaH2PO4
buffer solutions, for pH 7, 8, and 9, following guidelines from the Sigma Aldrich
Buffer Reference Center. Complete buffer exchange was afforded by two steps of
concentration using a AMICON ultra-filtration unit. Briefly, the protoxin sus-
pension at pH 11 was concentrated 50 times using a 10 kDa cutoff (Sigma Aldrich,
France), and then diluted 50 times in the buffer of interest (pH 7, 8, 9, or 10); this
two-step procedure was repeated twice to achieve a complete buffer exchange.
Suspensions were then added to Laemmli buffer devoid of DTT. To test the sta-
bility of the disulfide-linked dimer, each sample at each pH was heated for 5 min at
95, 100, 105, 110, 115, 120, 125, or 130 °C prior to loading on a SDS-PAGE 12%
gel. Each temperature was tested in triplicate. Gels were stained by overnight
incubation in InstantBlue (Sigma Aldrich, France), washed twice in ultrapure water
and digitalized using a ChemiDoc XRS+ imaging system controlled by the Image
Lab software version 6.0.0 (BioRad, France). The relative intensity of the bands
corresponding to Cyt1Aa dimers was estimated using the software ImageJ v1.51k41.
Insect and mammalian cells. The effect of the Cyt1Aa toxin was tested on three
different cell lines, namely an insect cell line (Sf21 cell line originating from Spo-
doptera frugiperda) and two mammalian cell lines (NIH 3T3 mouse fibroblast cells
and HEK293 human kidney embryonic cells). Sf21 cells were purchased from
Thermo Fisher Scientific (Riverside, CA, USA) and cultured in Sf-900 II SFM
(Serum-Free Medium) (GIBCO, insect culture media from Invitrogen), supple-
mented with Antibiotic Antimycotic Solution (100 UmL−1 penicillin, 100 μg mL−1
streptomycin, 0.25 μg mL−1 amphotericin B; Sigma) at 27 °C. NIH 3T3 cells (brand
name “CRL-1658”) were obtained from the American Type Culture Collection
(ATCC; Manassas, VA, USA) and cultured in high glucose DMEM medium (Life
Technologies), supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/
streptomycin at 37 °C. HEK293 cells (brand name “Freestyle HEK 293-F cells”)
were purchased from Thermo Fisher Scientific (Lyon, France) and cultured in
FreeStyleTM 293 medium (Gibco) at 37 °C with 5% CO2.
Cytotoxicity assays. Cytotoxicity of WT Cyt1Aa and of its mutants was assayed
on HEK293 cells (Figs. 3 and 4e–g and Supplementary Fig. 14). Being mono-
disperse in solution, these are indeed perfectly suited for cell toxicity assays at
different concentrations using FACS flow cytometer systems. For Cyt1Aa WT, four
conditions were tested: (1). Crystals solubilized in 0.1 M Na2CO3 buffer, pH 11.8,
yielding a disulfide-linked dimer of Cyt1Aa; (2). Same as condition (1) supple-
mented with 1 mM DTT, yielding the 27.3 kDa (unactivated) protoxin monomer;
(3). Same as condition (1) with activation by proteinase K for 1 h at 37 °C, yielding
the 23 kDa activated toxin monomer; (4). Same as condition (3) supplemented with
1 mM DTT, to assess the impact of DTT on the 23 kDa activated toxin monomer.
The same four conditions were tested for the mutants C7S and C190V. For all
other mutants, only two conditions were tested: crystals solubilized in presence of
DTT (monomeric protoxins) and toxins activated by proteinase K. A total of 10
doses was tested in each condition. For each dose of each WT or mutant toxin in
each condition, a total of 1 million cells suspended in 1 mL of FreeStyleTM 293
medium (Gibco) were incubated with the toxin at different concentrations and
with 1 μg mL−1 of PI for 15 min. Cells were then inoculated into a MACS Quant
VYB FACS (Milenyi Biotec) at a flow rate of 1000 cells s−1. They were sorted
according to their fluorescence at 617 nm (channel B2—built-in filter 589–639 nm
range) upon laser excitation at 488 nm. Raw data were treated and extracted using
the MACSQuantify software v2.11. Cell mortality was calculated by dividing the
number of cells counted positive for PI staining by the total number of sorted cells
(Supplementary Fig. 14). Mortality data were corrected using Abbott’s formula to
account for natural mortality in the control56. The best fitted model was selected
among four logistic regression models for binomial distribution (logit, probit,
complementary log-log transformation (cloglog) and Cauchy distribution) by
comparing their deviance using a script modified from54. For each WT or mutant
toxin species in presence or absence of DTT, LC50 (doses leading to death of 50% of
cell population) and 95% confidence intervals (CI) were calculated with the
binomial distribution and a Pearson’s chi square goodness-of-fit test, respectively,
as implemented in the software R 3.5.242,54. Differences in LC50 between conditions
were considered significant when 95% CI did not overlap55.
FITC-dextran cells exposure. The adherent insect Sf21 and NIH 3T3 cell lines
were used to visualize the Cyt1Aa-induced morphological changes, determine the
dimension of membrane lesions and assess the specificity of Cyt1Aa mode of action
(Fig. 5b, c and Supplementary Fig. 13). Sf21 and NIH cells were exposed to
increasing concentrations of activated Cyt1Aa toxin, during 30 min at 27 °C and
37 °C respectively. Cells were then incubated with a solution of fluorescein
isothiocyanate-dextran (FITC-dextran, or FD/from Sigma) at 4.5 mg.mL−1. We
selected two different dextran particles radius (FD-4, 1.4 nm and FD-150S, 8.5 nm).
Cells were imaged using a laser scanning confocal microscope (LSM), Zeiss LSM
510, using an argon laser at 488 nm for the FITC-dextran solution (Laboratory for
Fluorescence Dynamics, University of California Irvine, Irvine, CA). The emission
was collected using a 500–550 nm band pass filter. For the time series, a solution of
Cyt1Aa toxin plus FITC-dextran was incubated with the cells. The images were
taken during the first 20 min of intoxication. A time series stack of a 100 con-
secutively scanned frames was collected at 1.2 s−1. Once the stack was saved, a new
series was collected—and so on, for an entire runtime of 20 min.
BLM experiments. The porous nature and permeability characteristics of Cyt1Aa
MBO were tested by the BLM electrophysiological approach (Fig. 5a). Potassium
Chloride (KCl) and N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) were
purchased from Sigma Aldrich Chemical Co. Inc. The multi-channel recording
apparatus consisted of a two compartment Teflon chamber (~5 mL each) separated
by a Teflon compartment with 300 μm diameter aperture for membrane formation.
Bilayer lipid membranes were formed with 1% Asolectin in 4% Butanol in n-
Decane. The aperture was pretreated with 2% Asolectin in chloroform and was
allowed to cure for ~20 min to achieve solvent evaporation. The trans- and cis-sides
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of the chambers were filled with buffer solution, 300 mM KCl, 10 mM CAPS at pH
9. Half a microliter of lipid (1% Asolectin in 4% Butanol in n-Decane) was added to
the loop yielding a bilayer. Multi-channel reconstitution was achieved by addition
of ~1 μL purified Cyt1Aa from a series of dilutions (final Cyt1Aa concentrations
ranging from 1.7 to 60 μg mL−1) into the cis-side of the chamber. Channel current
traces were recorded with Ag/AgCl pellet electrodes (World Precision Instruments)
with the cis-side of the chamber being the virtual ground, using the Axopatch 200B
(Molecular Devices, LLC) patch-clamp amplifier in V-clamp mode (whole cell β =
1) with a CV-203BU headstage. The output signal was filtered by a lowpass Bessel
filter at 10 kHz, and saved at a sampling frequency of 50 kHz using an Axon
Digidata 1440A digitizer (Molecular Devices, LLC). Data analysis was performed
with clampfit (Molecular Devices (USA).
Oligomer formation and stoichiometry characterization. To test the different
conditions necessary for obtaining oligomers of Cyt1Aa protoxin and toxin, lipo-
somes were prepared by the standard film-hydration method as previously
described57. Briefly, liposomes were produced by drying L-α-phosphatidylcholine
(POPC; Avanti Polar Lipids, France) under nitrogen flow to obtain a thin lipid film.
Residual chloroform was eliminated by overnight vacuum. The lipid film was
resuspended in phosphate-NaCl buffer (0.1 M K2HPO4/KH2PO4, 0.15 M NaCl, pH
7.4) by vortexing for 5 min. The multilamellar vesicles obtained were freeze-thawed
(100–310 K) 20 times to obtain LUVs. Size calibration was performed either by
sonication in an ice-cold water bath for 5 min (yielding ~50 nm radius small
unilamellar vesicles or SUVs) or by extrusion using a mini-extruder (Avanti Polar
Lipids, France) with 200 nm polycarbonate filters (yielding ~100 nm radius large
unilamellar vesicles or LUVs). Homogenous size distribution was verified by
dynamic light scattering (DLS) on a Wyatt DynaPro NanoStar. Prepared liposomes
were directly used or stored for a maximum of 4 days at 4 °C until use.
The capacity of the three different forms (disulfide-bridged dimer, protoxin
monomer and toxin monomer) of WT and mutants Cyt1Aa to generate oligomers
upon contact with membranes was determined using SDS-PAGE 6% (Fig. 4c).
Samples were mixed with Laemmli buffer devoid of DTT, electrophoresed for
90 min at 140 V, and revealed using InstantBlue (Sigma Aldrich, France). The three
WT Cyt1Aa species that possibly co-exist in the mosquito larvae gut were tested,
namely the disulfide-bridged protoxin dimer (Fig. 4c, lanes 1–2), the protoxin
monomer (lane 3) and the activated toxin monomer (lanes 4–10). These were
subjected to different treatments including addition of DTT at 10 mM (lanes 3 and
6); exposure to LUV (lanes 2–3, 5–7, 9 and 10) or SUV (lane 8); heating to 95 °C
(lane 7); treatment with LDAO detergent at 2 times its CMC (Critical Micelle
Concentration) before (lane 9) or after the addition of toxin to the LUV (lane 10).
Kinetics of oligomerization were assayed by exposing the protoxin and toxin
monomers to LUVs for 15 different durations (2, 5, 7, 10, 12, 15, 30, 45 min and 1
h, 1 h 30 min, 2 h, 2 h 30 min, 3 h, 3 h 30 min, 4 h) prior to loading on SDS-PAGE
6% (Supplementary Fig. 10). Gels were stained as described above and digitalized
using a ChemiDoc XRS+ imaging system controlled by the Image Lab software
version 6.0.0 (BioRad, France). The distance between each band in the oligomer
population was determined using the software ImageJ v1.51k41. The influence of
different detergents was investigated (Supplementary Fig. 11) by incubating pre-
formed oligomers as described above with non-ionic (Tween-20, DDM, LDAO),
zwitterionic (CHAPS, CHAPSO) and ionic detergents (SDS) at 2 times their CMC
for 1 h. Samples were thereafter loaded on native PAGE (6% acrylamide),
electrophoresed for 2 h at 110 V, and stained and digitalized as described above.
To determine the toxin unit form that underlies the formation of the oligomers
(Fig. 4d), crystals of Cyt1Aa WT were solubilized in 0.1 M Na2CO3 buffer, pH 11.8.
Protoxin monomers were generated by addition of 10 mM DTT, while activated
toxin monomers were obtained by addition of trypsin at a final concentration of
0.1 mg mL−1. Oligomers were formed upon addition of LUV (100 nm radius; 5 mg
mL−1 POPC) to the protoxin and toxin monomers, and incubation for 2 h at RT.
The oligomer/LUV suspension was treated with LDAO at 4 mM final
concentration (i.e., ~2 times its CMC in water) to disrupt all liposomes still intact.
Solubilized oligomers were concentrated and purified using a 50 kDa cutoff
AMICON ultra-filtration unit (Sigma Aldrich, France) which allowed to discard
the remaining monomeric toxin, free POPC and LDAO monomers and mixed
lipid/LDAO micelles. Oligomers formed either by the protoxin or the activated
toxin, in the presence or the absence of DTT, were electrophoresed on a 15% SDS-
PAGE gel either directly after incubation or after heating to 95 °C for 5 min thereby
destabilizing oligomers, respectively. Unheated samples were also investigated by
TLC enabling quantification of their lipid content (see below). Gels were stained
and digitalized as described above. The relative intensities of bands corresponding
to oligomer populations and to the monomer were calculated using the software
ImageJ v1.51k41. To confirm SDS-PAGE results on unit basis of oligomers,
unheated samples from condition 1 were also examined by MALDI-ToF using
methods described above (Supplementary Fig. 6).
Determination of oligomer lipid content by TLC. TLC (Fig. 4d) was performed
using 10 × 20 cm aluminum pre-coated TLC-sheets ALUGRAM Xtra SILGUR/
UV254 (Macherey Nagel, France) containing a 0.2 mm layer of silica gel. Oligomer
samples recovered after concentration and purification on a 50 kDa cutoff AMI-
CON ultra-filtration unit (see above) were loaded on the concentrating zone (layer
of kieselgur) of the TLC sheets. Two concentrations and two duplicates were tested
for each sample and a concentration range of lipids (from 0.5 to 50 μg) was also
deposited for lipid concentration determination. Samples were allowed to migrate
in a glass tank containing 50 mL of a 65:35:5 chloroform:methanol:water mixture.
After 40 min. migration, phospholipids were specifically stained by spraying
molybdatophosphoric acid (1–5% in ethanol; Macherey-Nagel, France) on the
sheets and revealed by heating using a heat block. The intensity of each band was
analyzed using the software ImageJ v1.51k41.
Oligomer visualization by TEM. For negative stain TEM observations (Fig. 5n–q),
3 μL of sample were applied to the clean side of carbon on a carbon-mica interface
and stained with 2% sodium silicotungstate. Micrographs were recorded on a FEI
Tecnai T12 microscope operated at 120 kV with a Gatan Orius 1000 camera, at a
nominal magnification of ×49,000 resulting in a pixel size of 1.26 Å. For cryo-EM
observations, 3 μL of sample were applied to glow-discharged quantifoil grids 300
mesh 1.2/1.3 (Quantifoil Micro Tools GmbH, Germany), excess solution was
blotted with a Vitrobot (FEI) and the grid frozen in liquid ethane58. Data collection
was performed on a FEI F20 microscope operated at 300 kV under low dose
conditions. Images were recorded on a CETA camera (FEI) at a nominal magni-
fication of ×50,000 corresponding to a pixel size of 2.09 Å. Images were converted
into the TIFF format and then imported into the software ImageJ v1.51k41 to
calculate the length and curvature of oligomers.
Kinetics of toxin oligomerization and membrane perforation. Interaction
between Cyt1Aa activated toxin and reconstituted SLB was imaged on the same
Multimode 8 AFM as described above in fluid conditions (Fig. 5d–m). On a freshly
cleaved mica, a drop of 36 μL of buffer (100 mM Phosphate, 150mM KCl) was
deposited followed by a drop of 4 μL of previously prepared liposomes. This pre-
paration was left at room temperature for 2 h or overnight in a humid environment.
Weakly bound material was removed by rinsing three times with 40 μL of buffer (at
each rinse, 40 μL is removed and subsequently 40 μL of fresh buffer is added). Before
adding the protein, a drop of 40 μL of fresh buffer was deposited on the supported
bilayers on the mica. Native membranes were imaged first and if a proper fusion was
observed (large areas of uninterrupted supported bilayers), the drop was replaced by
40 μL of fresh buffer and 4 μL of the toxin at a concentration of 4 mg mL−1 was
injected in the drop. ScanAsyst fluid cantilevers (k = 0.7 Nm−1, Fq = 150 kHz,
nominal tip radius= 20 nm, Bruker probes, Camarillo, CA, USA) were used. 512 ×
512 pixel images were collected at ~1 Hz rate, with scan sizes varying from 7 to 1.7
μm in length, using the ScanAsyst mode in a semi-automatic condition where both
the gain and the set-point (from 40 to 120 mV) were manually adjusted. The default
ramp size for the peak-force mode was kept at 150 nm.
TIFF images were imported into the software ImageJ v1.51k41 to calculate the
surface of each oligomer as a function of elapsed time since toxin addition.
Considering that the data did not follow a normal distribution (Shapiro–Wilk test,
W = 0.92, p < 2.2 × 10−16, W = 0.96, p = 0.12; W = 0.91, p < 2.2 × 10−16), the
linear correlation between (i) the size of the oligomer and the elapsed time since
toxin addition (Fig. 5g); (ii) the hole depth and the hole surface (Fig. 5j); and
(iii) the hole depth and the hole + MBA surface (Fig. 5k) was tested using non-
parametric Spearman’s Rho rank correlation coefficients, as implemented in the
software R 3.5.242. Plot correlograms and 95% confidence regions were generated
using the “ggpubr”, “corrplot” and “Hmisc” libraries.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Structures and structure factor amplitudes have been deposited in the PDB databank
under accession codes 6T14 (“pH7”; [10.2210/pdb6T14/pdb]), 6T19 (“DTT”; [10.2210/
pdb6T19/pdb]), 6T1A (“pH10”; [10.2210/pdb6T1A/pdb]) and 6T1C (“C7S mutant”;
[10.2210/pdb6T1C/pdb]). The source data for Figs. 3, 4a–g, 5d–h and 5j–q and for
Supplementary Figs. 5, 7–12 and 14b are provided as a Source Data file. Other data are
available from the corresponding author upon reasonable request.
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